Daratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation
Clinical trial NCT03792620 · UNKNOWN
Trial details
- NCT number
- NCT03792620
- Sponsor
- Grupo de Estudos Multicentricos em Onco-Hematologia
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2020-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.